Prognostic Factors in Patients with Persistent Full-Thickness Idiopathic Macular Holes Treated with Re-Vitrectomy with Autologous Platelet Concentrate

2019 ◽  
Vol 242 (4) ◽  
pp. 214-221 ◽  
Author(s):  
Valentin Degenhardt ◽  
Catharina Busch ◽  
Claudia Jochmann ◽  
Petra Meier ◽  
Jan Darius Unterlauft ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Platelet Concentrate ◽  
Full Thickness ◽  
Macular Holes ◽  
Autologous Platelet Concentrate ◽  
Idiopathic Macular Holes ◽  
Autologous Platelet

Autologous platelet concentrate for the treatment of full-thickness macular holes

1995 ◽  
Vol 233 (9) ◽  
pp. 549-554 ◽  
Author(s):  
Alain Gaudric ◽  
Pascale Massin ◽  
Michel Paques ◽  
Pierre-Yves Santiago ◽  
Jean-Eric Guez ◽  
...  
Keyword(s):  
Platelet Concentrate ◽  
Full Thickness ◽  
Macular Holes ◽  
Autologous Platelet Concentrate ◽  
Autologous Platelet

Autologous platelet concentrate in the treatment of macular holes

1997 ◽  
Vol 94 (12) ◽  
pp. 877-881 ◽  
Author(s):  
F. Faude ◽  
E. Edel ◽  
M. Dannhauer ◽  
C. Petzel ◽  
P. Meier ◽  
...  
Keyword(s):  
Platelet Concentrate ◽  
Macular Holes ◽  
Autologous Platelet Concentrate ◽  
Autologous Platelet

scholarly journals Therapeutic Efficacy of Autologous Platelet Concentrate Injection on Macular Holes with High Myopia, Large Macular Holes, or Recurrent Macular Holes: A Multicenter Randomized Controlled Trial

2021 ◽  
Vol 10 (12) ◽  
pp. 2727
Author(s):  
Mirinae Kim ◽  
Jae-Yon Won ◽  
Seung-Yong Choi ◽  
Minhee Kim ◽  
Ho Ra ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Functional Outcomes ◽  
High Myopia ◽  
Controlled Trial ◽  
Platelet Concentrate ◽  
Randomized Controlled ◽  
Macular Holes ◽  
Multicenter Randomized Controlled Trial ◽  
Autologous Platelet Concentrate ◽  
Autologous Platelet

We aimed to evaluate the anatomical and functional outcomes of pars-plana vitrectomy (PPV) with or without autologous platelet concentrate (APC) injection in patients with recurrent macular holes (MHs), large MHs, or MHs with high myopia. This multicenter, prospective, interventional randomized controlled trial was conducted from March 2017 to April 2020. Participants were randomly allocated to a PPV group or a PPV+APC group. All participants underwent standard 25-gauge PPV, and eyes in the PPV+APC group underwent PPV with intravitreal APC injection before air-gas exchange. A total of 117 patients were enrolled (PPV group: n = 59, PPV+APC group: n = 58). Hole closure was achieved in 47 participants (79.7%) in the PPV group and 52 participants (89.7%) in the PPV+APC group. There were no between-group differences in the anatomical closure rate or functional outcomes including best-corrected visual acuity, metamorphopsia, pattern-reversal visual evoked potential, or Visual Function Questionnaire-25 score. The use of APC injection does not improve the anatomical and functional outcomes of surgery for large MHs, recurrent MHs, or MHs with high myopia. The adjunctive use of APC can be considered in selected cases because it is not inferior to conventional MH surgery, is relatively simple to perform, and is not affected by the surgeon’s skill.

Autologous Platelet Concentrate as an Adjunct in Macular Hole Healing

Ophthalmology ◽  
1996 ◽  
Vol 103 (4) ◽  
pp. 590-594 ◽  
Author(s):  
Jean-François Korobelnik ◽  
Daniele Hannouche ◽  
Nacera Belayachi ◽  
Michel Branger ◽  
Jean-Eric Guez ◽  
...  
Keyword(s):  
Macular Hole ◽  
Platelet Concentrate ◽  
Autologous Platelet Concentrate ◽  
Hole Healing ◽  
Autologous Platelet
Sign in / Sign up

Export Citation Format

Share Document